Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


Articles published in Emerg Infect Dis

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    March 2018
  1. NGUYEN DT, Teeter LD, Graves J, Graviss EA, et al
    Characteristics Associated with Negative Interferon-gamma Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.
    Emerg Infect Dis. 2018;24:534-540.
    PubMed     Text format     Abstract available


  2. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Text format     Abstract available


  3. ALTHOMSONS SP, Hill AN, Harrist AV, France AM, et al
    Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
    Emerg Infect Dis. 2018;24:573-575.
    PubMed     Text format     Abstract available


  4. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Text format     Abstract available


  5. BRENT AJ, Nyundo C, Langat J, Mulunda C, et al
    Prospective Observational Study of Incidence and Preventable Burden of Childhood Tuberculosis, Kenya.
    Emerg Infect Dis. 2018;24:514-523.
    PubMed     Text format    


  6. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Text format     Abstract available


  7. YEN YF, Pan SW, Su VY, Chuang PH, et al
    Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1).
    Emerg Infect Dis. 2018;24:498-505.
    PubMed     Text format     Abstract available


    November 2017
  8. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
    Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
    Emerg Infect Dis. 2017;23:1887-1890.
    PubMed     Text format     Abstract available


  9. TAO NN, He XC, Zhang XX, Liu Y, et al
    Drug-Resistant Tuberculosis among Children, China, 2006-2015.
    Emerg Infect Dis. 2017;23:1800-1805.
    PubMed     Text format     Abstract available


    October 2017
  10. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


  11. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


  12. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


    March 2017
  13. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Text format     Abstract available


  14. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Text format     Abstract available


  15. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Text format     Abstract available


  16. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Text format     Abstract available


  17. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Text format     Abstract available


  18. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Text format     Abstract available


  19. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Text format     Abstract available


  20. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Text format     Abstract available


  21. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Text format     Abstract available


  22. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
    Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
    Emerg Infect Dis. 2017;23:504-506.
    PubMed     Text format     Abstract available


  23. MILLER MA, Buss PE, van Helden PD, Parsons SD, et al
    Mycobacterium bovis in a Free-Ranging Black Rhinoceros, Kruger National Park, South Africa, 2016.
    Emerg Infect Dis. 2017;23:557-558.
    PubMed     Text format     Abstract available


  24. DAVIDSON JA, Loutet MG, O'Connor C, Kearns C, et al
    Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
    Emerg Infect Dis. 2017;23:377-386.
    PubMed     Text format     Abstract available


  25. SURIE D, Fane O, Finlay A, Ogopotse M, et al
    Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
    Emerg Infect Dis. 2017;23:487-490.
    PubMed     Text format     Abstract available


    February 2017
  26. DENNING DW, Perlin DS, Muldoon EG, Colombo AL, et al
    Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


    December 2016
  27. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
    Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
    Emerg Infect Dis. 2016;22:2178-2180.
    PubMed     Text format     Abstract available


    September 2016
  28. KVASNOVSKY CL, Cegielski JP, van der Walt ML
    Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


    June 2016
  29. MOKROUSOV I, Chernyaeva E, Vyazovaya A, Sinkov V, et al
    Next-Generation Sequencing of Mycobacterium tuberculosis.
    Emerg Infect Dis. 2016;22:1127-9.
    PubMed     Text format    


    March 2016
  30. STORY A, Garfein RS, Hayward A, Rusovich V, et al
    Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  31. CLAASSENS MM, van Schalkwyk C, Dunbar R, Ayles H, et al
    Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available



  32. Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  33. THAPA J, Paudel S, Sadaula A, Shah Y, et al
    Mycobacterium orygis-Associated Tuberculosis in Free-Ranging Rhinoceros, Nepal, 2015.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format    


  34. PEZZOLI L, Gounder S, Tamani T, Daulako MR, et al
    Tuberculosis, Fiji, 2002-2013.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  35. TUPASI TE, Garfin AM, Kurbatova EV, Mangan JM, et al
    Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  36. DIERBERG KL, Dorjee K, Salvo F, Cronin WA, et al
    Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  37. BASAVARAJ A, Chandanwale A, Patil A, Kadam D, et al
    High Tuberculosis Risk among Medical Trainees, Pune, India.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  38. SULLIVAN T, Ben Amor Y
    Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  39. STAGG HR, White PJ, Riekstina V, Cirule A, et al
    Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  40. PARPIA AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP, et al
    Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa.
    Emerg Infect Dis. 2016;22:433-41.
    PubMed     Text format     Abstract available


  41. TSCHAMPL CA, Garnick DW, Zuroweste E, Razavi M, et al
    Use of Transnational Services to Prevent Treatment Interruption in Tuberculosis-Infected Persons Who Leave the United States.
    Emerg Infect Dis. 2016;22:417-25.
    PubMed     Text format     Abstract available


  42. SHARMA A, Bloss E, Heilig CM, Click ES, et al
    Tuberculosis Caused by Mycobacterium africanum, United States, 2004-2013.
    Emerg Infect Dis. 2016;22:396-403.
    PubMed     Text format     Abstract available


  43. RAJU RM, Raju SM, Zhao Y, Rubin EJ, et al
    Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
    Emerg Infect Dis. 2016;22:365-9.
    PubMed     Text format     Abstract available


  44. FURIN J, Brigden G, Lessem E, Rich M, et al
    Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2016;22.
    PubMed     Text format     Abstract available


  45. CHORBA T, Breedlove B
    Depictions of Heroism in Battle and Anguish from Tuberculosis.
    Emerg Infect Dis. 2016;22:573-4.
    PubMed     Text format    


    November 2015
  46. ERSHOVA JV, Volchenkov GV, Kaminski DA, Somova TR, et al
    Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
    Emerg Infect Dis. 2015;21:2048-51.
    PubMed     Text format     Abstract available


  47. ACHAR J, Berry C, Herboczek K, Parpieva N, et al
    Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Emerg Infect Dis. 2015;21:2105-6.
    PubMed     Text format    


  48. PEREZ-LAGO L, Lirola MM, Navarro Y, Herranz M, et al
    Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Emerg Infect Dis. 2015;21:2098-100.
    PubMed     Text format    


  49. KIM JH, Yim JJ
    Achievements in and Challenges of Tuberculosis Control in South Korea.
    Emerg Infect Dis. 2015;21:1913-20.
    PubMed     Text format     Abstract available


    August 2015
  50. DOBLER CC, Korver S, Batbayar O, Nyamdulam B, et al
    Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011.
    Emerg Infect Dis. 2015;21:1451-1454.
    PubMed     Text format     Abstract available


  51. LIAO TL, Lin CH, Shen GH, Chang CL, et al
    Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011.
    Emerg Infect Dis. 2015;21:1387-95.
    PubMed     Text format     Abstract available


    June 2015
  52. KEMPKER RR, Kipiani M, Mirtskhulava V, Tukvadze N, et al
    Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2015;21:992-1001.
    PubMed     Text format     Abstract available


  53. SMITH SE, Ershova J, Vlasova N, Nikishova E, et al
    Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005-2010.
    Emerg Infect Dis. 2015;21:1002-11.
    PubMed     Text format     Abstract available


  54. KURBATOVA EV, Dalton T, Ershova J, Tupasi T, et al
    Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
    Emerg Infect Dis. 2015;21:977-83.
    PubMed     Text format     Abstract available


  55. WILLIAMS OM, Abeel T, Casali N, Cohen K, et al
    Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing.
    Emerg Infect Dis. 2015;21:1082-4.
    PubMed     Text format    


  56. ACOSTA F, Chernyaeva E, Mendoza L, Sambrano D, et al
    Mycobacterium bovis in Panama, 2013.
    Emerg Infect Dis. 2015;21.
    PubMed     Text format     Abstract available


    March 2015
  57. TRIEU L, Proops DC, Ahuja SD
    Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.
    Emerg Infect Dis. 2015;21:500-3.
    PubMed     Text format     Abstract available


  58. CHIU NC, Lin MC, Lin WL, Wang SY, et al
    Mycobacterium bovis BCG-associated osteomyelitis/osteitis, Taiwan.
    Emerg Infect Dis. 2015;21:539-40.
    PubMed     Text format    


  59. MUSOKE J, Hlokwe T, Marcotty T, du Plessis BJ, et al
    Spillover of Mycobacterium bovis from wildlife to livestock, South Africa.
    Emerg Infect Dis. 2015;21:448-51.
    PubMed     Text format     Abstract available


  60. RAMDAS KE, Lyashchenko KP, Greenwald R, Robbe-Austerman S, et al
    Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012.
    Emerg Infect Dis. 2015;21:480-3.
    PubMed     Text format     Abstract available


  61. GALLIVAN M, Shah N, Flood J
    Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.
    Emerg Infect Dis. 2015;21:435-43.
    PubMed     Text format     Abstract available


  62. THOMAS BS, Okamoto K
    Role of race/ethnicity in pulmonary nontuberculous mycobacterial disease.
    Emerg Infect Dis. 2015;21:544-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: